Publications
- Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidlines related to the diagnostics and treatment of dyslipidemias issued in 2011 +32013 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Hypertriglyceridemia and cardiovascular risk2012 | First Faculty of Medicine
- Cholesterol homeostasis and cardiovascular risk2011 | First Faculty of Medicine
- The effect of high density lipoprotein on atherogenesis and increase in its concentration induced by CETP inhibiton2010 | First Faculty of Medicine
- Rosuvastatine2009 | First Faculty of Medicine
- Hyperlipidemia is associated with altered levels of insulin-like growth factor-I2008 | First Faculty of Medicine
- Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: the effect of atorvastatin treatment2008 | First Faculty of Medicine
- 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Second Faculty of Medicine
- Statement CSAT on Consensus statement of the European Atherosclerosis Society: Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
- ČSAT opinion on the EAS 2021 Consensus: Lipoproteins rich in triglycerides and their remnant particles - overview of metabolism, role in atherosclerotic cardiovascular disease and new therapeutic strategies2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Second Faculty of Medicine
Loading network view...